Indiana Biosciences Research Institute
The Indiana Biosciences Research Institute (IBRI) is an American nonprofit translational research organization headquartered in Indianapolis, Indiana, United States within the 16 Tech Innovation District. The IBRI is the nation's first industry-led collaborative life sciences research institute. Its primary focus is on better understanding the pathogenesis of type 1 and type 2 diabetes to translate this knowledge into novel therapies, while also expanding into other metabolic diseases that share common systems and pathways.
Innovation Building 1 at 16 Tech Innovation District | |
| Formation | May 1, 2013 |
|---|---|
| Type | Research Institute |
| Headquarters | Indianapolis, Indiana, U.S. |
Region served | Indiana |
Staff | 100 |
| Website | http://indianabiosciences.org |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.